血管内皮抑素,Endostatin
1)Endostatin血管内皮抑素
1.Correlation of Pretreatment Serum Level of Endostatin to Posttreatment Distant Metastasis in Patients with Advanced Nasopharyngeal Carcinoma;治疗前外周血血管内皮抑素浓度与局部晚期鼻咽癌治疗后远处转移的关系
2.Advances in Endostatin Therapy for Non-small Cell Lung Cancer;血管内皮抑素在非小细胞肺癌治疗中的研究进展
3.Research on the Antitumor Effect of Endostatin Associate with Chemotherapy and Discussion of Its Mechanisms;血管内皮抑素联合化疗抗肿瘤疗效观察及机制讨论
英文短句/例句

1.Outlook of endostatin inhibit ocular neovascularization血管内皮抑素对眼内新生血管抑制的展望
2.Research on the Effect of Endostatin on Lewis Lung Carcinoma;血管内皮抑素对lewis肺癌细胞直接效应的观察
3.Current progression of endostar on clinical application and research重组人血管内皮抑素临床应用和研究的新进展
4.Experimental Study on Treatment of Mouse Hemangioma by Recombinant Human Endostatin;重组人血管内皮抑素治疗鼠源性血管瘤的实验研究
5.Clinical application of recombinant human endostatin重组人血管内皮抑制素临床应用进展
6.Studies on Experimental Choroidal Neovascularization Inhibited by Endostatin Genetherapy;内皮抑素抑制脉络膜新生血管的实验研究
7.Experimental Study on the Inhibition of Corneal Neovascularization with Recombinant Human Endostatin;重组人内皮抑素抑制角膜新生血管的实验研究
8.NUMERICAL SIMULATION OF INHIBITORY EFFECTS OF ENDOSTATIN ON TUMOR ANGIOGENESIS内皮抑素抑制肿瘤血管生成的数值模拟
9.Effects of endostatin on the expression of vascular endothelial growth factor in the retina of oxygen-induced retinal neovascularization内皮抑素对视网膜新生血管中血管内皮细胞生长因子表达的影响
10.Serum levels and clinical significance of vascular endothelial growth factor and endostatin in patients with carcinoma of large intestine大肠癌患者血清血管内皮生长因子和内皮抑素水平的变化
11.Biological Properties and Recombinant Human Vascular Endostatin Therapy of Hemangioma: Study on Hemangioma Endothelial Cells in Vitro Culture血管瘤内皮细胞的生物特性和重组人血管内皮抑制素对血管瘤内皮细胞作用的实验研究
12.Expression of endostatin in gastric cancer and its relationship with vascularization胃癌中内皮抑素表达与血管形成的关系
13.Recent advances on the modified endostatin and ocular neovascularization改良内皮抑素与眼部新生血管的研究进展(英文)
14.Anti-inflammatory Effect of ABL in Experimental De-endothelium and Hyperlipidemia Rats;旋覆花素抑制血管内皮剥脱和高脂血症所致的血管炎性反应
15.Cloning, Expression, Purification and Partial Characterization of Endostatin, Mig and Angiostatin;内皮抑素、Mig和血管抑素的克隆、表达、纯化及初步活性鉴定
16.A Study on the Expression, Mechanism and Intervention of Endostatin and Angiostain in Myocardial Infarction Rats;心肌梗死大鼠内皮抑素、血管抑素的表达及其机制和干预研究
17.An Experimental Study of Anti-Angiogenesis with Low Mocular Weight Heparin Endostatin;低分子肝素化内皮抑素抑制兔角膜新生血管的实验研究
18.Mechanism and Effects of Glucose on Endostatin Expression in Vascular Endothelial Cells;葡萄糖对血管内皮细胞内皮抑素表达的影响及其调控机制的研究
相关短句/例句

endostatin血管内皮抑制素
1.Pharmacokinetics of recombinant human endostatin in healthy volunteers and patients with advanced solid tumors;重组人血管内皮抑制素的人体药动学
2.Progress of a novel antitumour drug-Endostatin;抗肿瘤新药血管内皮抑制素的研究进展
3.Anti-Tumor Effect of Recombinant Human Endostatin on the Growth of Mouse Lewis Lung Carcinoma;重组人血管内皮抑制素对小鼠Lewis肺癌肿瘤抑制作用
3)Human endostatin人血管内皮抑素
1.Objective To clone human endostatin gene, purify its expression protein and detect its biological activity.目的 克隆人血管内皮抑素基因(endostatin),纯化其表达蛋白并初步检测纯化蛋白的生物学活性。
4)Endostatin·Carcinoma血管内皮抑素·癌
5)recombinant human Endostatin重组人血管内皮抑制素
1.Clinical application of recombinant human endostatin重组人血管内皮抑制素临床应用进展
2.The fermentation process of recombinant human Endostatin expression in Escherichia coli BL21 (DE3) was studied.优化了重组人血管内皮抑制素的E。
3.In order to instruct reasonable application of the recombinant Human Endostatin ,the development in clinical research of Endostar for malignant tumor were reviewed in this paper,including clinical results,drug adverse reactions and qulity of life.介绍重组人血管内皮抑制素(恩度)治疗恶性肿瘤的临床研究情况,包括临床疗效、不良反应和生活质量方面的研究进展,为临床合理应用和评价新药提供参考。
6)recombinant human endostatin重组人血管内皮抑素
1.Inhibitory effects of recombinant human endostatin on the metastatic potential and invasiveness of hepatocellular carcinoma HCCLM6 cells in vitro;重组人血管内皮抑素体外对肝癌HCCLM6细胞转移侵袭的影响
2.Assessment of the cardiotoxicity of recombinant human endostatin using myocardial biochemical markers in cancer patients;心肌生化标志物联合检测评价重组人血管内皮抑素心脏毒性
3.Intravenous drip transfusion of recombinant human endostatin combined with arterial infusion chemotherapy for the treatment of advanced carcinomas: a clinical observation静脉滴注重组人血管内皮抑素联合动脉灌注化疗治疗晚期恶性肿瘤的临床观察
延伸阅读

舒血管素 ,血管舒缓素药物名称:血管舒缓素英文名:Kallidinogenase别名: 保妥丁;激太积放酶;舒血管素 ,血管舒缓素外文名:Kallidinogenase适应症: 用于脑动脉硬化症、闭塞性动脉内膜炎、闭塞性血管炎、四肢慢性溃疡、肢端动脉痉挛症、手足发绀、老年性四肢冷感、中央视网膜炎、眼底出血等。也用于冠心病、心绞痛、视网膜血流障碍。 用量用法: 1.注射:临用时溶解(每1.5ml10单位)后进行肌注或皮注1次量10~20单位,每日1~2次。轻症每日10单位,以3周为1疗程。眼科亦可作眼结膜下注射,每次5单位。 2.口服:每次1片(含10单位),空腹时服。 注意事项: 1.凡肿瘤、颅内压增高、心力衰竭病人忌用。 2.有些病人应用后可出现疼痛反应。 3.本品对热、酸、碱、氧化剂均不稳定。 规格: 注射用血管舒缓素:每支10单位。片剂:每片10单位。 类别:周围血管扩张药